BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11084688)

  • 1. Fibroblasts and dermal gene therapy: a minireview.
    Krueger GG
    Hum Gene Ther; 2000 Nov; 11(16):2289-96. PubMed ID: 11084688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated cutaneous gene delivery: the skin as a bioreactor.
    Cao T; Wang XJ; Roop DR
    Hum Gene Ther; 2000 Nov; 11(16):2297-300. PubMed ID: 11084689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genodermatoses: candidate diseases for gene therapy.
    Uitto J; Pulkkinen L
    Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic correction of inherited epidermal disorders.
    Khavari PA
    Hum Gene Ther; 2000 Nov; 11(16):2277-82. PubMed ID: 11084686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating and regulating immune responses through cutaneous gene delivery.
    Larregina AT; Falo LD
    Hum Gene Ther; 2000 Nov; 11(16):2301-5. PubMed ID: 11084690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal stem cells as targets for gene transfer.
    Watt FM
    Hum Gene Ther; 2000 Nov; 11(16):2261-6. PubMed ID: 11084684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic aspects of expression of stably integrated transgenes in cells of the skin in vitro and in vivo.
    Krueger GG; Morgan JR; Petersen MJ
    Proc Assoc Am Physicians; 1999; 111(3):198-205. PubMed ID: 10354359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
    Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
    Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted single-base correction by RNA-DNA oligonucleotides.
    Igoucheva O; Yoon K
    Hum Gene Ther; 2000 Nov; 11(16):2307-12. PubMed ID: 11084691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin, a privileged target for gene therapy].
    Descamps V
    Presse Med; 1995 May; 24(19):882-4. PubMed ID: 7638126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-mediated gene transfer for cutaneous gene therapy.
    Ghazizadeh S; Taichman LB
    Hum Gene Ther; 2000 Nov; 11(16):2247-51. PubMed ID: 11084682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preclinical model for the analysis of genetically modified human skin in vivo.
    Del Rio M; Larcher F; Serrano F; Meana A; Muñoz M; Garcia M; Muñoz E; Martin C; Bernad A; Jorcano JL
    Hum Gene Ther; 2002 May; 13(8):959-68. PubMed ID: 12031128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonviral skin gene therapy.
    Vogel JC
    Hum Gene Ther; 2000 Nov; 11(16):2253-9. PubMed ID: 11084683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy.
    Ghazizadeh S; Harrington R; Taichman L
    Gene Ther; 1999 Jul; 6(7):1267-75. PubMed ID: 10455435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene delivery to the epidermis.
    Trainer AH; Alexander MY
    Hum Mol Genet; 1997; 6(10):1761-7. PubMed ID: 9300669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
    Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microencapsulated VEGF gene-modified umbilical cord mesenchymal stromal cells promote the vascularization of tissue-engineered dermis: an experimental study.
    Han Y; Tao R; Han Y; Sun T; Chai J; Xu G; Liu J
    Cytotherapy; 2014 Feb; 16(2):160-9. PubMed ID: 24438897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in skin gene therapy.
    Pfützner W; Vogel JC
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2069-83. PubMed ID: 11060793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the kinetics of interferon transgene expression for improved gene therapy.
    Watcharanurak K; Nishikawa M; Takahashi Y; Takakura Y
    J Drug Target; 2012 Nov; 20(9):764-9. PubMed ID: 22994266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cloned genetically modified human fibroblasts to assess long-term survival in vivo.
    Krueger GG; Jorgensen CM; Petersen MJ; Mansbridge JN; Morgan JR
    Hum Gene Ther; 1997 Mar; 8(5):523-32. PubMed ID: 9095404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.